#101

Mohammadreza Mohamadreza Sheikh Sheikh Sajjadieh

Membrane Dynamics Index Identifies Immune-Inflamed and Immune-Desert States in Lung Adenocarcinoma

#102

Le Hoang

Exploring STING response within dendritic cells to improve immunotherapy efficacy

#103

Georgia Dow

Investigating CD4⁺ and CD8⁺ T cell responses to a nested peptide

#104

Janin Chandra

Circulating CD5⁺ dendritic cells link gut microbiome function to immunotherapy response in cancer patients

#105

Simon Manuel ST Tria

Co-culture platform of patient derived organoids and autologous T cells to discover novel immunotherapeutic options

#106

Venkateswar Addala

Tumour antigen atlas for paediatric brain cancer vaccine development

#107

Aditya Manna

Financial Toxicity and Access Barriers to Cancer Immunotherapy in Low- and Middle-Income Countries: Perspectives from Rural Eastern India

#108

Shiyi Wu

Leveraging mRNA–LNP Technology for In Vivo CAR Immune-Cell Engineering

#109

Gabriel Goncalves

Circulating HLA Ligandomes Reflect Tumour Antigen Landscapes in Pathological Non-Responding (pNR) Melanoma Treated with Neoadjuvant Immune Checkpoint Inhibitors (ICI).

#111

Wanxiaojie Xie

Preclinical Evaluation of Cytokine-Adjuvanted Multivalent MVA Vaccines Encoding Influenza A Virus and SARS-CoV-2 Antigens

#112

Rachel Song

From Throat to Skin: Bacteria-Triggered Autoimmunity Shaped by Genetic Susceptibility

#113

Zoe Magill

The unintended effects of melanoma targeted therapies on dendritic cell-mediated immune responses

#114

Misty R Jenkins

Tumour-directed PD-L1×CD137 bispecific immunomodulation unlocks curative multi-target CAR T cell therapy in glioblastoma

#115

Misty R Jenkins

PDGFRa-CAR T cells induce sustained remission in a representative model of disseminated pediatric high-grade glioma

#116

Danielle Blud

Optimising a machine learning algorithm for immunotherapy target identification in brain cancer

#117

Ludivine Grzelak

Revealing dose and repeat effects of a novel Influenza vaccine on humoral immunity

#118

Jin Ng

Understanding the Role of γδ T Cells in Immunotherapy Responses in Small Cell Lung Cancer

#119

Milie M Desai

Exploring CAR T cell therapy and immunomodulatory agents in immunocompetent paediatric brain cancer models

#120

Vivian Tran

Integrating human and experimental models to identify immune mechanisms underlying cardiovascular complications in Long COVID.

#121

Javad Masoumi

Identification of shared immunogenic non-canonical HLA-A*02:01-presented peptides for therapeutic cancer vaccine development in BRCA-deficient breast cancer

#122

Matilda Doran

Microbiota-derived choline metabolites improve CD8⁺ T cell responses and correlate with ICI efficacy in melanoma patients

#123

Maleika Osman

Precision engineering of CAR-T cells for tumour-restricted secretion of cytokines in a novel syngeneic multiple myeloma model

#124

Laila Karra Khalil

A novel allogeneic Tissue Factor-targeted CAR-NK cell therapy for endometriosis

#125

Tima Shamekhi

Antigen discovery for cancer immunotherapy in paediatric diffuse midline glioma: from H3K27M neoantigens to dark antigens

#126

Anurag Adhikari

Immune Biomarkers Reveal Divergent Cellular and Humoral Responses Following Repeated Pfizer SARS-CoV-2 Booster Vaccination

#127

Keziah Ting

RNA-Seq profiling demonstrates enhanced cytotoxicity, persistence and manufacturing consistency in CTH-401, a late-preclinical-stage off-the-shelf CAR NK cell product.

#128

Sining Li

Persistent low antigen during chronic infection sustains potent CD8+ effector T cell responses that drive severe immunopathology

#129

Elham Shokati

A Single Cell Transcriptomic Atlas of CD8+ Cytokine-Induced Killer Cells from Metastatic Colorectal Cancer Patients

#130

Ashleigh S Davey

Structural tuning of CAR potency for tailored anti-CD19 CAR-T cell therapies

#131

Yoseph Adel YW Wahba Molano

A patient-derived CAM platform for rapid evaluation of glioblastoma therapies and future modelling of tumour–immune interactions

#132

Farnaz Fahimi

Development of monoallelic cell lines with non-classical HLAs

#133

Purva Trivedi

Myeloid cell-specific HCK shapes fibrotic tumour microenvironment in pancreatic cancer through macrophage-fibroblast crosstalk

#134

Hannah Walker

immune profiling reveals upregulation of profibrotic & JAK-STAT signalling as a mediator of post-HSCT lung complications in children

#135

Brittany Doran

Preclinical development of tissue factor-targeted iPSC-derived CAR-NK cells for solid tumours

#136

Ryan s Cross

Designing Novel Versatile Protease Regulatable Chimeric Antigen Receptor (VIPER) T Cell Therapies For High Grade Glioma

#137

Harry L Horsnell

Local Invasion of Melanoma Metastasis into Lymph Nodes Drives Spatially Restricted Immunosuppressive Niches Underpinned by Distinct Fibroblastic Populations

#138

Kiho Tanaka

Establishment of advanced human immune system mouse models

#139

Abhinaya Muraly

Butyrate-Driven Memory Precursor CD8⁺ T Cell Differentiation Requires Fatty Acid Synthesis

#140

Lacey Klompmaker

Treatment with recombinant IFNe induces a rapid interferon response in human endometrial epithelial organoids

#141

Jamie Tuibeo

Investigation of the immune response to HIV in a Nepalese cohort

#142

Chloe E Jackson

Microbiota-mediated epithelial crosstalk and IL-21-Stat3 signalling in γδ T Cells for improved immunotherapy in colorectal cancer

#143

Presenter announcing soon

Investigating Vδ1⁺ γδ T Cells in Primary Thymus and Artificial Thymic Organoids for Immunotherapeutic Applications

#144

Yannick Alexandre

The splenic fibroblastic microenvironment regulates exhausted T cell responses during chronic infection and checkpoint blockade

#145

Tina Z Zhang

Leveraging the Therapeutic Potential of Human Vδ3⁺ T Cells

#146

Anuratha Sakthianandeswaren

Patient Derived Tumour Organoid (PDTOs) models to advance immunotherapy approaches for Oral Squamous Cell Carcinoma (OSCC)

#147

Ryan S Cross

HSP90B1 targeting Chimeric Antigen Receptor (CAR) T cell therapy is effective in the treatment of solid tumours

#148

Zahra Taylor

Comparing therapeutic immunosuppression by the CTLA4-Ig fusion proteins abatacept and belatacept

#149

Daniel T Utzschneider

B cell lymphoma promotes regulatory T cell response to escape CD4⁺ T cell-mediated cytotoxicity and responses to checkpoint blockade

#150

Yuxi Cao

Follicular T cell program including CXCR5 and ICOS regulates exhausted T cell responses to chronic infection and cancer

#151

Galih GA Adhyatma

Suppressing the suppressors – new antibody strategies in cancer immunotherapy

#152

Xiaomin Wang

Structural and Functional Characterisation of LRRC15 Recognition by Therapeutic Monoclonal Antibody and Engineered Minibinders

#154

Bahar Naseri

Preclinical evaluation of a Clec9A-targeted polyhydroxybutyrate nanovaccine for cancer immunotherapy

#155

Maximilien Evrard

Spatially organised danger sensing selectively remodels intestinal tissue-resident lymphocytes

#158

Liam Neil

Employing Natural Killer Cells to Reveal Weaknesses in Breast Cancer

#159

Hugh Chalmers

Developing an ex vivo tissue platform to predict patient response to neo-adjuvant immunotherapy for triple negative breast cancer.

#160

Mark R Dowling

ctDNA-directed intervention with epcoritamab alone or in combination with lenalidomide and rituximab is feasible in the early post-CAR-T population at high risk of relapse: Interim results from EpLCART

#162

Rifqa Fayaz

Investigating changes in the absence of the cytokine negative regulator Cytokine-Inducible SH2-Containing Protein (CISH) following influenza A virus infection

#163

Yasmin M Lewis

Combination PD-1/CTLA-4 blockade diminishes the ovarian reserve, extends time to natural conception and impairs early offspring growth in mice.

#164

Mark R. Dowling

A signature of early myeloid and endothelial activation in severe ICANS derived from high-dimensional serum proteomics

#165

Cindy CA Audiger

A clinical grade type 1 dendritic cell manufacturing leveraging BATF3 expression and notch signalling

#166

Thiago Maass Steiner

Tumour microenvironments supporting close tumour–T-cell interactions and CD4⁺ T-cell cytotoxic differentiation underpin response to glofitamab in diffuse large B-cell lymphoma

#167

Pailene S Lim

Identifying multi-stage vaccine targets against Plasmodium falciparum malaria

#168

Evie Van Emmerik

Developing a Stem Cell Derived Human Alveolar Epithelial Model

#169

Jasmine JM Chuah

IFNε: A Novel Immunomodulator in High-Grade Serous Ovarian Cancer

#170

Md Jahangir Alam

Targeted depletion of CX3CR1⁺ immune cells attenuates joint and skin inflammation in mouse models of rheumatoid arthritis and atopic dermatitis

#171

Seyed Mohammad MJ Javadzadeh

Development of Spatial Immunopeptidomics for Tissue-Resolved Mapping of Antigen Presentation

#172

Yining Tian

Genomic Alterations in TNF-Related Cell Death Pathways as Potential Biomarkers for Personalized Therapy in Oral Squamous Cell Carcinoma

#173

Nancy Wang

B cells play an essential role in programming CD4⁺ T cell memory development following intracellular bacterial infection

#174

Anju Abraham

Mapping the Development of Protective Immunity and Relapse Risk in Plasmodium vivax Using Longitudinal Systems Immunology

#175

Lorraine A O'Reilly

Cell death therapy tailored combination with CAR T-cells or conventional treatment for late-stage head and neck cancer

#176

Shengbo Zhang

CAR-DC1: A novel next-generation dendritic cell therapy for targeting solid tumours

#177

Kellie Mouchemore

Using spatial transcriptomics and machine learning to identify biomarkers of immunotherapy response in TNBC

#178

Sanjay Sondekoppa Gopala Krishna

Computational identification and validation of cancer-specific neoantigens using CAN-IMMUNE

#179

Matthias Ernst

Inhibition of IL6 trans-signalling rewires the immune-suppressive myeloid compartment, limits liver metastases and identifies actionable colon cancer patients